Your browser doesn't support javascript.
loading
Durable response to crizotinib in metastatic angiomatoid fibrous histiocytoma with EWSR1-CREB1 fusion and ALK overexpression.
Ngo, C; Grinda, T; Boilève, A; Levy, A; Le Pechoux, C; Haddag, L; Valent, A; Lazure, T; Briand, S; Honoré, C; Faron, M; Mir, O; Bahleda, R; Verret, B; Le Cesne, A.
Afiliação
  • Ngo C; Department of Biology and Pathology, Gustave Roussy, Villejuif, France; Université Paris-Saclay, Faculté de Médecine, Le Kremlin-Bicêtre, France.
  • Grinda T; Department of Cancer Medicine, Gustave Roussy, Villejuif, France.
  • Boilève A; Université Paris-Saclay, Faculté de Médecine, Le Kremlin-Bicêtre, France; Department of Cancer Medicine, Gustave Roussy, Villejuif, France.
  • Levy A; Université Paris-Saclay, Faculté de Médecine, Le Kremlin-Bicêtre, France; Department of Radiation Oncology, Gustave Roussy, Villejuif, France.
  • Le Pechoux C; Department of Radiation Oncology, Gustave Roussy, Villejuif, France.
  • Haddag L; Department of Radiology, Gustave Roussy, Villejuif, France.
  • Valent A; Department of Biology and Pathology, Gustave Roussy, Villejuif, France.
  • Lazure T; Department of Pathology, Bicêtre Hospital, Université Paris-Saclay, Le Kremlin-Bicêtre, France.
  • Briand S; Department of Orthopaedics and Traumatology, Bicêtre Hospital, Université Paris-Saclay, Le Kremlin-Bicêtre, France.
  • Honoré C; Department of Surgery, Gustave Roussy, Villejuif, France.
  • Faron M; Department of Surgery, Gustave Roussy, Villejuif, France.
  • Mir O; Department of Ambulatory Cancer Care, Gustave Roussy, Villejuif, France.
  • Bahleda R; Department of Cancer Medicine, Gustave Roussy, Villejuif, France.
  • Verret B; Department of Cancer Medicine, Gustave Roussy, Villejuif, France.
  • Le Cesne A; Department of Cancer Medicine, Gustave Roussy, Villejuif, France. Electronic address: axel.lecesne@gustaveroussy.fr.
Ann Oncol ; 33(8): 848-850, 2022 08.
Article em En | MEDLINE | ID: mdl-35568279

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Histiocitoma Fibroso Benigno / Histiocitoma Fibroso Maligno Limite: Humans Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Histiocitoma Fibroso Benigno / Histiocitoma Fibroso Maligno Limite: Humans Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França